Browse drugs

…, and B16F10 models. Combinational synergy was also tested with capecitabine and oxaliplatin chemotherapy, as well as with partial surgical …

…, the patients will receive CapeOX combined with sintilimab and IBI305 at the recommended phase II dose. The primary objectives will b…

…s Adult patients (>18 years) prescribed at least four cycles of oxaliplatin, cisplatin, docetaxel or paclitaxel were clinically assessed an…

…ounded 60 bags of 19 different drugs, including 5-fluorouracil, bevacizumab, carboplatin, cisplatin, cyclophosphamide, docetaxel, doxorubic…

…is cohort, high AXL predicted worse OS in patients treated with fluorouracil, leucovorin, and oxaliplatin/fluorouracil, leucovorin, and irin…

…uorouracil, cisplatin+fluorouracil and oxaliplatin+leucovorin + fluorouracil regimens were administered to 46 (67%), 4 (6%) and 19 (27%) pat…

…ed four cycles of adjuvant chemotherapy with the XELOX regimen (capecitabine plus oxaliplatin) in accordance with the current treatment guid…

…ved total neoadjuvant therapy (TNT) consisting of six cycles of capecitabine–oxaliplatin followed by long-course chemoradiotherapy, resultin…

…mastobart, and no treatment-related deaths occurred.Conclusions Nelmastobart combined with capecitabine demonstrated a manageable safety pro…

… with clinical outcomes ( figure 1). The PDTOs are sensitive to 5-FU, oxaliplatin, irinotecan and their combination (figure 2). Howe…

…c therapy, and 44% of patients with epithelial cancer had prior oxaliplatin or irinotecan exposure. Minimally invasive resection was perfor…

… with an objective response.Conclusions mKRAS-VAX combined with ipilimumab and nivolumab was well-tolerated and resulted in clinical respo…